Biotech stocks Roivant and Pharvaris hit records Tuesday on "blowout" and "bull case" results for lung and swelling disease treatments.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Biotech Stocks, With 'Blowout' And 'Bull Case' Results, Rocket To Record Highs ·
Investor's Business Daily
